PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2160719
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2160719
According to Stratistics MRC, the Global Maternal & Fetal Monitoring Technologies Market is accounted for $3.0 billion in 2026 and is expected to reach $4.9 billion by 2034 growing at a CAGR of 6.2% during the forecast period. Maternal & Fetal Monitoring Technologies comprise advanced medical devices and digital solutions designed to evaluate maternal and fetal health during pregnancy and childbirth. They track important indicators including fetal heart rate, uterine activity, maternal vital signs, oxygen saturation, and other physiological measures. Key technologies include electronic fetal monitoring, cardiotocography, wearable monitoring devices, ultrasound systems, and remote monitoring platforms. By providing continuous or periodic health assessments, these technologies help clinicians recognize complications earlier, guide treatment decisions, and strengthen monitoring during pregnancy, labor, delivery, and early postpartum care.
According to the World Health Organization (WHO), about 260,000 women died during and following pregnancy and childbirth in 2023, demonstrating the continuing need for effective maternal monitoring, early risk detection, and timely obstetric intervention.
Rising high-risk pregnancies and maternal complications
Growing numbers of high-risk pregnancies are increasing the need for Maternal & Fetal Monitoring Technologies. Pregnancy-related conditions, including gestational diabetes, hypertension, preeclampsia, obesity, and older maternal age, often require continuous assessment. Advanced monitoring solutions allow clinicians to observe fetal heart activity, contractions, maternal vital signs, and other important physiological indicators. Detecting concerning changes earlier can facilitate faster medical intervention and help limit adverse outcomes. As a result, hospitals, obstetric departments, and maternity facilities are adopting sophisticated monitoring technologies to enhance pregnancy management and support safer maternal and fetal care.
High cost of advanced monitoring systems
Expensive advanced Maternal & Fetal Monitoring Technologies can limit their widespread adoption, especially across resource-constrained healthcare systems. Modern fetal monitoring equipment, wireless sensors, wearable solutions, ultrasound devices, and connected platforms involve significant expenses for procurement, installation, maintenance, software integration, and personnel training. Additionally, inadequate reimbursement and limited healthcare expenditure can discourage technology purchases. These financial barriers can therefore delay implementation and contribute to unequal availability of sophisticated maternal and fetal monitoring technologies across different healthcare settings.
Expansion of remote maternal and fetal monitoring
Growing use of remote healthcare creates promising opportunities for Maternal & Fetal Monitoring Technologies. Wearable sensors, wireless devices, smartphone applications, and cloud platforms enable maternal and fetal parameters to be monitored outside conventional healthcare facilities. Such solutions can strengthen follow-up for high-risk pregnancies and extend access to specialized obstetric care in areas with limited medical resources. Remote monitoring may also minimize avoidable hospital visits while allowing clinicians to evaluate patient information and detect potential concerns. Increasing digitalization of healthcare is consequently opening new applications for connected maternal and fetal monitoring solutions.
Cybersecurity risks and data breaches
Greater connectivity across Maternal & Fetal Monitoring Technologies increases vulnerability to cybersecurity incidents and unauthorized data access. Wireless monitoring equipment, wearable solutions, cloud-based platforms, and integrated healthcare systems handle sensitive maternal and fetal information that could attract cyber threats. Security incidents, ransomware attacks, or technical disruptions may affect privacy and interfere with monitoring activities. Such risks can make healthcare providers cautious about adopting connected technologies. Manufacturers must continually improve authentication, encryption, cybersecurity controls, and data protection, which can add complexity, investment requirements, and ongoing maintenance costs.
The COVID-19 pandemic influenced the Maternal & Fetal Monitoring Technologies Market by restricting conventional prenatal appointments and creating challenges for routine maternity care. Healthcare organizations expanded telehealth, remote monitoring, wearable technologies, and connected platforms to continue assessing maternal and fetal health while minimizing unnecessary hospital exposure. Supply-chain interruptions and deferred medical procedures temporarily constrained equipment utilization. However, the pandemic accelerated digital transformation in maternal healthcare, increased acceptance of remote monitoring approaches, and highlighted their importance for maintaining pregnancy surveillance during periods of healthcare disruption.
The non-invasive monitoring segment is expected to be the largest during the forecast period
The non-invasive monitoring segment is expected to account for the largest market share during the forecast period because it provides comfortable and safer methods for assessing maternal and fetal health without invasive intervention. External sensors, ultrasound technologies, wearable devices, and other non-invasive systems allow healthcare professionals to perform regular monitoring efficiently. These approaches are commonly favored throughout pregnancy because they minimize discomfort and procedural concerns. Their convenience, adaptability, and ability to support repeated examinations contribute to widespread utilization across hospitals, clinics, and various maternity healthcare environments.
The homecare settings segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the homecare settings segment is predicted to witness the highest growth rate as maternity care increasingly embraces convenient and patient-focused approaches outside hospitals. Wearable sensors, remote monitoring platforms, connected devices, and digital healthcare tools allow maternal and fetal conditions to be assessed from home. These solutions can facilitate monitoring between scheduled clinical appointments, especially for pregnancies requiring closer observation. Growing acceptance of virtual healthcare, expanding connectivity, and preferences for accessible maternity services are encouraging wider adoption of monitoring technologies in home-based care.
During the forecast period, the North America region is expected to hold the largest market share because of its well-developed healthcare infrastructure and strong utilization of advanced monitoring solutions. Hospitals and maternity facilities widely implement electronic fetal monitoring, ultrasound, telemetry, and connected technologies to support maternal and fetal care. Established healthcare systems, reimbursement mechanisms, specialized obstetric services, and leading medical technology providers contribute to regional adoption. Increasing focus on high-risk pregnancies and continuous monitoring during pregnancy and childbirth further supports North America's dominant market position.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving maternity healthcare infrastructure, greater prenatal-care awareness, and increasing use of sophisticated monitoring systems. China and India are expanding obstetric facilities and strengthening access to pregnancy-related healthcare services. Rising institutional births and stronger emphasis on maternal and fetal well-being are supporting adoption. Additionally, the region's substantial population base, improving healthcare availability, and growing investment in portable, digital, and connected monitoring technologies are creating favorable conditions for accelerated market expansion.
Key players in the market
Some of the key players in Maternal & Fetal Monitoring Technologies Market include Philips Healthcare, GE HealthCare, Medtronic, Siemens Healthineers, Mindray Medical International, Nihon Kohden, Natus Medical, Neoventa Medical, ArjoHuntleigh (Arjo), Edan Instruments, Contec Medical Systems, Bionet, Luckcome, Sunray Medical Apparatus, Medgyn Products, DIXION, Dormed Hellas and Advanced Instrumentations.
In April 2026, GE HealthCare announced an expanded collaboration with DeepHealth, Inc, to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and women's health.
In October 2025, Philips Healthcare and Getinge have formed a new commercial partnership in Europe to offer customers easier access to a complete anesthesia and monitoring solution. By combining Philips' monitoring solutions with Getinge's leading anesthesia care products, the partnership provides a single point of contact for purchasing and support, helping clinicians deliver high-quality care in the operating room.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.